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PROGRAMME OF THE RESEARCH 
1.  INTRODUCTION 
The assessment of the biological effects on man by his daily exposure 
to the heavy metal pollution of the environment would require a  compre-
hensive knowledge of the biochemical action of pollutants at the concentra-
tion in which they are normally present in polluted environments. 
However,  the experimental difficulties associated in long-term experi-
ments carried out with metal concentrations which are usually in the part 
per billion range,  are rather high,  and in practice most of the knowledge 
available on biochemical effects of pollutants is based upon short-term ex-
periments,  carried out with concentrations of heavy metals which are much 
higher than those present in polluted environments. 
Differences in systematic manifestations between acute and chronic ex-
posure have been experimentally found,  but the basic mechanisms involved 
are still far from being explained,  even for elements of major concern 
( 1' 2)  such as C d,  Pb,  Hg.  • 
Among the few studies reported on the binding of metals at environmental 
levels with specific cellular components and their biotransformations are 
those reported on metallothionein (a specific protein of liver and kidney 
which might act as a  detoxication agent for cadmium) and nickeloplasmin, 







For a  large number of heavy metals which might be classified as pollu-
tants of minor concern,  only a  few data are available on their biochemical 
effects,  even at more massive doses. 
It may therefore be stated that: 
- there is a  need to distinguish,  at least for pollutants of major concern 
such as Cd,  C r,  Hg,  Pb and Zn,  between the biochemical effects of acute 
exposures and those of chronic exposures as may result from daily expo-- 6  -
sures to a  polluted environment; 
- there is a  need to provide more systematic information on the bioche-
mical effects of pollutants which were reported as possible environmen-
tal contaminants and for which a  few biochemical effects were demon-
strated. 
Such studies are greatly hindered by experimental difficulties such as: 
- the necessity of "labelling" for in vivo studies nanogram or sub-nanogram 
amounts of metals (a problem which may be difficult even for very sensi-
tive techniques such as radioactive tracing); 
- the necessity of detecting and measuring trace amounts of metals in mi-
crosamples of cellular components which are obtained after long and com-
plex separation procedures. 
2.  CHOICE OF POLLUTANT METALS 
We have selected 5 elements (Cd,  Zn,  Se,  Hg and Cr) for the long term 
experiments and 4  elements {Pb,  V,  Ni,  Be) for the short term experiments. 
We also planned to carry out some works on As,  Tl,  Mo,  Te,  Bi and Sn, 
.  .  .  h  .  (6,7,8,9,10,11)  .. 
wh1ch are presently rece1v1ng muc  attent1on  for the1r 1mpact 
at biochemical level and antagonism or competition with pollutants of major 
concern. 
The choice was not simply based on the concept of biological essentiality 
and toxicity.  In fact,  metals differ .from most other pollutants in that often 
they can have an essential biological function in addition to a  toxic role. 
As an example Zn and Se,which are essential as constituent of alkaline phos-
phatase(lZ) and glutatione peroxidase(l 3)  enzymes when present in excessive 
quantities,  are as toxic as Cd,  Hg and Pb which are known as environmen-
tal contaminants without essential biological function. 
General criteria to determine which elements are most likely to pollute - 7  -
the environment,  have been recently reported.  Wood(l
4
) classified pollu-
tants elements as: 
1) non critical {Fe,  Si,  Rb,  Al,  Na,  K,  Mg,  Ca,  P,  S,  Cl,  Br,  F,  Li,  Sr); 
2) very toxic and relatively accessible (Be,  Co,  Ni,  Cu,  Zn,  Sn,.  As,  Se, 
Te,  Pd,  Ag,  Cd,  Pt,  Au,  Hg,  Tl,  Ph,  Sb,  Bi); 
3) toxic but very insoluble (Ti,  Hf,  Zr,  Re,  W,  Nb,  Ta,  Ga,  La,  Ir,  Os, 
Ru,  Ba). 
Fishbein  ( 
1 5
)  reported a  list of pollutants which may pose health hazard 
in the environment (Cd,  Se,  Hg,  Pb,  Be,  V,  As,  Mn,  B,  Y,  Sb,  Sn,  Ge, 
Zr,  Bi). 
The essential present knowledge on the behaviour at cellular level of 
the heavy metals which were chosen in the present research are summari-
zed below. 
Cadmium 
Cd progressively accumulated in the human organism with age,  parti-




).  This is attributed to a  protein,  metallo-
thionein,  (MW = 10, 000  ),  with an exceptionally high content of cysteine, 
which is synthesized following the administration of cadmium  (lS, 19).  After 
administration via inhalation,  ingestion or injection,  cadmium is transpor-
ted bound to both plasma and erythrocites proteins via blood to other tis-
sues in the body.  The metal enters the tissues of various body organs,  par-
ticularly in liver and kidney,  although testicles,  pancreas and spleen contain 
it(Zl).  The biological half-life of cadmium is extremely long and the turn-
over of metallothionein is practically unknown.  Although Piscator suggested 
that the protein could be continuously synthesized in chronic exposure to 
cadmium acting as a  detoxifying agent for this toxic metal,  the metabolic 
role of metallothionein is far from being understood(ZZ). - 8  -
Selenium 
The highest concentration of selenium in man was found in the liver, 
followed by the kidney,  spleen and lung. 
.  (23) 
Selenium has been shown to cross the placenta 1n rats  .  It could exert 
its toxic action by the oxidation of sulfhydril metabolites,  thus inactivating 
them.  It has also been suggested that selenium can compete with sulphur at 
those sites in which sulphur normally plays a  role in cellular metabolism, 
although the biosynthesis of selenoaminoacids from selenites in animals is 
not yet demonstrated(
24
).  Following absorption selenium is carried fixed 
in the red blood cells associated with plasma albumin and globulin which 
transport the metal to more stable binding sites in blood and tissues  (
2 s). 
Different effects were observed in rats intoxicated with selenates or sele-
nites.  It was found that selenate can be reduced to more toxic selenite and 
that the body could detoxify this latter by converting it in the volatile methyl 
s elenide  (26). 
Mercury 
The highest level of mercury in animals was found in kidneys,  followed 
by liver,  spleen and brain.  The subcellular distribution of inorganic mer-
cury shows that the metal is accumulated by the lysosomal fraction of liver. 
However,  differences were observed in the subceflular distribution between 
organic and inorganic mercury compounds(
27
).  Mercury is found bound to 
hemoglobin and albumin.  The reaction represents an equilibrium involving 
all the -SH groups of the proteins  {Z
8
).  The metal is also able to bind to both 
nuclear proteins and to DNA causing complex structural changes within 
DNA{29, 30). 
Chromium 
The subcellular distribution of chromium showed that the soluble fraction 
of heart,  pancreas and adipose tissue have the bulk of chromium in contrast 
to liver where it mainly accumulates in the microsomes. 
The distribution in liver fractions was altered by induced diabetes or by the - 9 -
feeding of high fat diets.  In particular,  when the rate of hepatic lipogenesis 
was normal or elevated,  chromium appeared to move from the nuclear to 
the microsomial fraction of liver(
3
l). 
C r(VI) has been recognized as the toxic form while C r(III) can form a 
complex with sulfhydril groups on the A-chain insulin acting as a  cofactor 
f .  1"  .  (32,33)  h  .  o  Insu In action  .  It was shown t  at chromium was associated with 




Lead metabolism follows closely that of calcium,  particularly in deposi-
tion and mobilization from bone.  After an acute exposure,  lead is found in 
the liver and kidney(3 S). 
At the cellular level the best known effect of lead is the inhibition of the 
enzymes which depend on -SH groups for their function.  The metal is im-
plicated in the metabolism of 0  -aminolevulinic acid (ALA) and therefore 
in the biosynthesis of heme from iron and protoporphyrin  (
36
). 





).  Baltrop shows that the metal is contained in the so-





Blood lead is found mainly associated with the erytrocytes.  However,  the 
binding site on the hemoglobin molecule is not known also if it was sugges-
ted that free  -SH groups are not essential in the formation of the lead-hemo-
globin complex(39). 
Beryllium 
Beryllium accumulates in all cells producing an insoluble beryllium phos-
phate removed from the circulating blood by the reticuloendothelial system 
of the liver(  40). 
Beryllium concentrates at subcellular level into lysosomes and nuclei of 
cells.  In particular it binds to rat liver nuclei with marked affinity and inhi-- 10  -
bition of the enzymes  required for DNA synthesis but with no effect on 
RNA metabolism.  However,  the nature of the binding site for beryllium 
in the nucleus is unknown(
4
l)_  Inhibition studies have shown that alkaline 
phosphatase,  phosphoglucomutase and adenosine phosphatase have high 
affinity for beryllium which reacts with the enzymes in a  very specific 
way(
4
z)_  It was shown that under certain circum stances beryllium is a 
carcinogen  ( 43). 
Vanadium 
Different effects were observed in animals intoxicated with vanadium 
compounds,  the most toxic form being the pentavalent followed by tri- and 
divalent. 
The established effects of vanadium salts at molecular level are: 




- inhibition of cholesterol biosynthesis at concentrations of 5 x  10  M  and 
lowering of phospholipids in the blood(
45
); 
.d  .  f  .  .  .  ( 46)  - ox1  ahon o  serotonin 1n v1tro  ; 
-inhibition of calf intestine alkaline phosphatase(
47
). 
Recently,  it has been shown that the toxic effect of vanadium in the rat 
is unrelated to Mo-antagonism and it is demonstrated that these effects 




The subcellular distribution of dietary nickel shows that it accumulates 
in the soluble fraction of the liver and in soluble fraction and nuclei of kid-
(49)  .  .  63  .  63 
ney  •  InJections of  N1C 1
2 
in rabbits show that serum  Ni can be s e-
parated into three components:  DZ-macroglobulin-bound 
63
Ni (nickeloplas-
63  63 







Ni in the subcellular fractions of liver 
and lung was approximately proportional to the dry weights of the respec-- 11  -
tive fractions,  the metal being bound to RNA,  DNA and proteins(SO)_ 
A  significant increase in the incidence of malignant tumors was observed 
in rats receiving i. v.  injections of nickel carbonyl.  An inhibition of en-
zymes induction in lung and liver was observed(Sl). 
3.  OUTLINE OF THE RESEARCH 
The research outlined below aims at the study,  uncle r  systematic ope-
ration conditions,  of the distribution of labelled metal pollutants at low-
dose in organs,  subcellular fractions and isolated and fractioned compo-
nents of subcellular fractions in view of identifying specific metal binding 
component. 
The complete research for each metal involves the following steps. 
3. 1  Preparation of r.adiotracers 
3. 2  Administration of the  tracer to a  group of animals 
3. 3 Sacrifice of the animals at various intervals of time,  dissection and 
radioactivity evaluation in different organs 
3. 4  Separation of subcellular fractions by differential centrifugation 
3. 5  Purification of organelles from subcellular fractions 
3. 6 Fractionation of purified organelles into their components 
3. 7  Chromatographic separation on organelles components 
3. 8  Isolation of individual metal binding components by analytical and pre-
parative electrophoresis on polyacrilamide gels. 
3. 9 Characterization of the metal binding component and in vitro  studies 
3. 10 In vivo studies 
Two types of experiments are envisaged,  here called: 
Long-term experiments: (up to 3-4 months) the labelled metal will be ad:mi-- 12  -
nistered via drinking water at low concentrations (environmental levels) 
over long periods of time in order to simulate as close as possible the 
conditions of polluted environments. 
Long-term experiments will be carried out on groups of 100 rats,  sacri-
ficed in groups of 10 animals at various intervals of time.  A  detailed 
scheme of the various experimental works which will be carried out for 
each metal is given in Table 1.  The procedure described is the most com-
plete one.  Adaptations will be done as long as the research proceeds to 
eliminate the non-essential steps. 
Short-term experiments: {1-7 days) the labelled metal will be injected at 
acute or subacute levels. 
They will be carried out on a  small number of animals as preliminary 
orientating experiments or to evidentiate differences between chronic and 
acute effects. 
3. 1  Preparation of the Radiotracers 
The systematic study is made possible by the availability of radiotracers, 
radiochemical facilities and highly selective measuring techniques,  not usu-
ally available to biochemical laboratories and which make it possible to la-
bel in vivo and in vitro  very minute amounts of pollutant metal.  The radio-
tracers of each element were selected on the basis of: 
1) possibility of obtaining very high specific activity, 
2) half-life sufficiently long for long-term experiments, 
3) easy detection of the emitted radiation. 
The preparations are essentially done: 
a) by proton irradiations in a  cyclotron, 
b) by neutron irradiations in a  nuclear reactor. 
Radioisotopes production in a  nuclear reactor by (n, "()  reaction and opti-
mum conditions for producing several isotopes have been already deve-- 13  -
loped during pr~vious years.  An irradiation facility will become avail-
able during 197  5 by the installation of a  hydraulic irradiation channel 
in the ESSOR reactor with a  neutron thermal flux of 3. 5 x  1 0
14 
neutrons 
-2  -1 
em  sec  •  By its use radioisotopes will be prepared both with very 
high specific activity and using nuclear reactions other than (n, o  ). 
Table 2  shows the nuclear data of the radioisotopes proposed for this 
study. 
3. 2  Administration of the Radiotracers 
The concentrated solutions of the radiotracers obtained in the preceed-
ing step will be stored in a  refrigerator.  Dilution for long-term experi-
ments will be carried out with well-characterized mineral water.  Exhaus-
tive preliminary experiments will be done to make sure that the tracer is 
taken by the animal in the desidered chemical form and that uncertainty of 
the chemical state,  lack of equilibrium of the diluted solution and absorp-
tion effects do not induce misleading experimental artifacts. 
3. 3 Sacrifice,  Dissection and Counting of Isolated Organs 
The animals will be sacrificed by heart puncture after ether anaesthesia. 
The following tissues will be separated: brain,  heart,  kidney,  liver,  spleen, 
muscle,  lung,  thyroid,  testes,  bone,  blood,  stomach,  G. I.  tract  • 
.  ~he organs will be weighed,  washed with buffer solution (a buffer per-
fusion will be done for liver or other organs,  if found necessary) and homo-
genized.  Homogenization will be done in a  refrigerated and shielded homo-
genizer which ensures maximum safety in case of rupture of the organ con-
tainer. 
Sacrifice and dissection will be carried out as rapidly as possible.  The 
organs will be kept refrigerated by ice baths,  in order to minimize bioche-
mical reactions inducing migration of metal ions among various subcellu-
lar fractions before homogenization. - 14 -
Aliquots of the homogenized organs will be taken for radioactivity mea-
surements while the rest of it will be frozen and stored for further hand-
ling. 
3. 4  Separation of Subcellular Fractions by Differential Centrifugation 
The separation of subcellular fractions will be carried out on those or-
gans which showed the most significant accumulation of the radiotracers. 
Liver and kidney will always be considered.  Cellular fractionation will be 
carried out in two steps: 
1) Nuclei and mitochondria  by preparative centrifuge, 
2) Lysosomes,  microsomes and soluble cytoplasmatic fraction by prepara-
tive ultracentrifuge. 
The procedures adopted will be the classical ones,  reported in the lite-
rature.  Fig.  1  shows the one for rat liver. 
Aliquots from the fractions  obtained will be taken for radioactivity eva-
luation,  the rest will be frozen and stored for further handling. 
3. 5 Purification of Subcellular Organelles from Subcellular Fractions 
Purification of the subcellular organelles will be carried out in order to 
minimize the effects of misleading cross -contaminations.  The most recent 
procedures reported in the literature will be applied.  The flow-sheets of a 
few of them (nuclei,  mitochondriae,  mic rosomes) are shown in Fig.  1. 
3. 6 Fractionation of Purified Organelles into their Components 
The organelles which will show a  significant acGumulation of the tracer 
will be submitted to procedures for the isolation of their components.  The 
most recent procedures reported in the literature will be applied.  The flow-
sheets of a  few of them (isolation and separation of subnuclear components, 
fractionation of mitochondria  and Golgi apparatus are shown in Fig.  2. 
They will mostly be carried out in a  cold room area at +4°C. - 15  -
3. 7  Chromatographic Separations on Organelles Components 
The most significant organelles components will be submitted to a 
successive fractionation into components of different molecular weight 
by gel chromatography.  In-line detection systems allow a  continuous mea-
surement of radioactivity and U. V.  absorption at two different wavelengths 
for continuous analysis of metal and protein content.  The effluent will be 
collected into separate fractions on which tests for specific enzymatic ac-
tivities will eventually be carried out. 
The most significant fractions will be pooled desalted by means of hal-
low fibres, lyophilized,  and kept for further handling. 
The presence of metals other than the ones labelled will be detected and 
quantitatively estimated by activation analysis of microsamples of the lyo-
philized product. 
3. 8 Analytical and Preparative Electrophoresis 
Analytical gel electrophoresis will be carried out on the most significant 
protein fractions.  U. V.  scanning of the gel will allow to isolate "electro-
phoretically pure" proteins.  The gel will then be divided into 1-2 mm slices 
and the radioactivity profile will be measured.  Activation analysis of indivi-
dual gel slices will allow identification and,  possibly,  quantitative estimate 
of metals other than the one labelled. 
Preparative electrophoresis will be carried out on the most significant 
fractions in order to obtain larger quantities of specific metal-binding com-
ponents for full characterization and successive in vitro studies. 
3. 9 Characterization of the Metal-Binding Component and in Vitro Studies 
Studies in vitro to characterize the metal-binding component identified 
by the systematic study outlined above will also be carried out: 
- elemental composition, - 16  -
- stoichiometric ratios, 
- identification of metal-binding sites, 
- saturation levels, 
- synergistic and antagonistic effects of other pollutants. 
Greatest advantage will be taken of an automatic dialyser being under con-
struction in order to minimize the operators time and to diminish the risk 
arising to persons from relatively high radiation levels. 
In particular the dialyser will allow the study in vitro of the interaction 
of heavy metals with metalloenzymes and nucleic acids,  already well known 
as potential metal binding sites.  It is known that heavy metals such as Hg 
and Cd alterate the structure of nucleic acid by interacting with phosphate 
groups and/or bases{SZ). 
In addition pollutant metals could interfere with the catalytic function by dis-
placing the essential native metal of metalloenzymes{S
3
). 
Because the extent of binding of metals to nucleic acids is extremely low 
and since the research on metalloenzymes must necessarily be carried out 
on very minute amounts of materials the availability of metals in radioac-
tive form with high specific activity is of very great help in these studies. 
3. 10 In Vivo Studies 
The following particular studies will be carried out in vivo after identi-
fication of the metal-binding component: 
- parameters which affect the accumulation of metals in the body, 
- influence of the chemical forms of the metal, 
- influence of the metal in the biosynthesis of the metal-binding component, 
- synergistic and antagonistic effects of other pollutants. - I 7  -
STATE OF ADVANCEMENT AND PRELIMINARY RESULTS 
4.  SET UP OF STABULARIUM AND COLD ROOM RADIOCHEMICAL 
FACILITIES 
Special modular type cages to minimize metal contamination have 
been developed.  A  particular water-supply device was developed in or-
der to minimize radioactive contamination of cages and animals.  The 
drops of water lost during the drinking process are recovered into a 
polyethylene bottle. 
Preliminary experiments showed that after administration of 
109
cd to 
rats the radioactive contamination in all the parts of the cage are insig-
nificant.  Feces and urines are collected into a  polyethylene container 
which can be directly counted to obtain data on the excretion of radio-
tracers. 
0 
A  cold room (area at + 4  C) radiochemical facility has been set up 
in order to minimize temperature depending artifacts during the fractio-
nation of the purified cellular organelles into their components.  The cold 
room has been equipped with gel chromatography (flow analyzers for mo-
nitoring UV absorption at 280 and 2 54 nm,  fully automatic fraction collec-
tors,  recorders,  peristaltic pumps and colum~of different size).  The cold 
area has been designed and especially equipped with high level of radio-
activity as required for some in vitro studies. 
Figure 3  shows the stabularium,  the various parts of the modular cage 
and the cold room radiochemical facility. 
5.  PREPARATION OF RADIOTRACERS WITH HIGH SPECIFIC ACTNITY 
Table 2  gives the nuclear pertinent data of the radioactive isotopes 
used for the proposed study.  Most of them have been prepared carrier-
free,  by proton irradiation at the cyclotron of the Milan University. 
The same laboratory has measured the excitation function for each iso-
tope to provide useful information on the possible contaminants from inter-
fering reactions and to allow a  proper choice of the bombarding energy. - 18  -
The knowledge of the excitation function is also essential to determine 
whether enriched targets must be used and the degree of enrichment 
which is necessary.  The separation from interfering radionuclides and 
target element,  the preparation for their biological use and the analytical 
controls have been set up by our laboratory.  Figure 4  shows as an exam-
48 
ple the experimental excitation function for the production of  V from 
metallic titanium targets. 
A  complete description of the production methodology will be reported 
elsewhere. 
6.  PRELIMINARY RESULTS ON BIOCHEMICAL EFFECTS OF CADMIUM 
Studies on the subcellular distribution of cadmium show that after a 
single injection the cellular cadmium was almost entirely present in the 
soluble fraction of liver and kidney(l
8
} bound to a  cadmium-binding pro-
tein {Cd-BP},  a  low molecular weight protein with a  high number of cyste-
ine residues {21  g atoms/mole of protein(
54
)).  For this the incorporation 
of 
35
s-cysteine in the Cd-BP was used to study the biosynthesis of the 
protein in Cd-treated rats in respect to normal animals.  In addition,  we 
have investigated in vivo the interaction of heavy metals with Cd-BP: 
- by neutron activation analysis of Cd-BP purified by gel chromatography, 
- by incorporation of radiotracers in the protein after administration of 
labelled metals to Cd-treated rats. 
6. 1 Isolation,  Purification,  Metal c·ontent and "De-Novo" Biosynthesis 
Of Rat Ll .ver 109cd and 
35
S-double L  b  11  d  C  d  ·  B"  d"  P  a  e  e  a  m1um- 1n  1ng  ro-
tein (Cd-BP) 
0  f  d  .  .  h  1 09c  d  3 5s  .  h  ne group o  rats was treate  1. p.  w1t  d an  -cysteine.  T  e 
animals were sacrificed by cervical dislocation after 24 h.  Liver tissues 
were homogenized in 0. 25M sucrose.  The soluble cytoplasmatic fraction 
was obtained by ultracentrifugation at 105.000 x  g  for 90 min.  Gel filtra-- 19  -
tion of soluble fraction was done with 10 mM Tris -HCl buffer,  pH=8. 2 
as eluant on Sephadex G-7 5 column.  UV absorbance of eluate was moni-
tored at 2 54 and 2 80 nrn by an LKB Uvico rd III instrument. 
Th 
109cd  d.  . .. h  1  db  e  ra  Ioact1v1ty 1n t  e  e  uate was measure  y  an autogamma 
(Nai(Tl) crystal) while the 
35
s  radioactivity was detected after separa-
tion by ion exchange chromatography of 
109 
Cd radioactivity. 
All ope rations were done in the cold room at 4 °  C. 
Homogeneity of the Cd-BP was verified by disk electrophoresis,  while 
neutron activation analysis was used to determine simultaneously various 
heavy metals in microsamples of determined protein.  The nuclear tech-
nique was also used to the metal content in the Cd-BP from gel chromato-
graphy after further purification by disk electrophoresis.  Electrophoretic 
separation was performed in duplicate.  The first gel was stained for pro-
teins,  while the second gel was sliced in small discs,  1 mm thickness, 
which were examined for their metal content by neutron activation analy-
sis. 
The results are shown in Figure 5: 
- a  new protein peak (Cd-BP) containing all 
109
cd radioactivity appears 
in UV profiles at 254 nm of Cd-treated rats,  absent in untreated con-
trols.  No protein peak appears at 280 nm (dotted line in the UV profile) 
because Cd-BP does not contain aromatic aminoacids(S
4
) (Figure SA); 
- a  much higher incorporation of 
35
s-cysteine was found in this peak in 
respect of controls (Figure SA); 
- the presence of the following elements has been demonstrated by neu-
tron activation analysis in the Cd-BP isolated by gel chromatography: 
Cd,  Zn,  Cu,  Hg,  Ag and traces of Fe,  As,  Mn,  Sb,  Sc,  Cs and Au. 
A  typical gamma-ray spectrum of the neutron activated rat liver Cd-BP 
is shown in Figure SB; 
- Cd,  Zn,  Hg and Cu of the Cd-BP have similar profiles in the gel after 
disk electrophoresis (Figure SC ).  The C d-BP,  which is homogeneous - 20  -
in terms of molecular weight,  seems not to be electrophoretically 
homogeneous.  This was confirmed by measuring also 
35
S-cysteine 
radioactivity in the gel: the profile after electrophoresis was similar 
h  f 
109cd  h  .  .  d"  "b  .  .  k  to t  at o  s  owing a  maximum  Istri ution In two pea  s. 
6. 2  Identification of Cd-BP in Rat Testicles and Spleen 
To establish if Cd-BP could be present in rat testicles and spleen, 
one group of 10 rats was treated with 
109
cd carrier-free.  The animals 
were sacrificed after 24 hand the soluble fraction isolated and fractioned 
6  1  109  d"  as described under section  •• The results show that all  Cd ra IOac-
tivity was present in fractions corresponding to Cd-BP although the pro-
tein was too low to be detected in the  UV profile. 
109 
However,  while in liver {Figure  5A} and testicles (Figure 6A} the  Cd 
is associated only with Cd-BP of low molecular weight,  in the spleen the 
109
cd is also present in high molecular weight components (Figure 6B}. 
6. 3  Incorporation of Radioactive Metals into Cd-BP 
Recently Nordberg observed that Cd-BP could play a  more general 
role in the metabolism of various heavy metals  (l )•  For this,  to provide 
systematic information on the relative incorporation into Cd-BP of rat 
liver under in vivo conditions,  one group of rats received a  single intra-




and radioactive metal,  while a  second 
group,as a  check,  received only the radioactive metal like the first group 
109 
but without  CdC1
2
•  After 24 h  the Cd-BP was isolated as described in 
section 6. 1. 
65  197  64  110m  113 
From 21 metals tested,  only  Zn,  Hg,  Cu,  Ag and  Sn 
were found incorporated into "de novo" biosynthesized Cd-BP. 
Figure 7  shows the results obtained. - 21  -
6. 4. l  Effects of Heavy Metals on the Biosynthesis of Cd-BP 
In order to prove that the incorporation of cadmium is not affected 
b  h  l  f  .  d  .  l  .  .  .  f  109cd  y  any ot er meta ,  one groupo  rats receive  a  Sing e  InJection o 
and 
35
S-labelled cysteine in the presence of other metals,  while a  second 
109  35 
group,  as a  check,  received only  Cd and  S-labelled cysteine without 
other metals. 




35s radioactivities measured in the Cd-BP fraction.  The 
results show that both incorporation of cadmium and the biosynthesis of 
Cd-BP are not influenced by the presence of other metals such as: 




2+  2+  2+  2+  .2+  3+  3+ 
Cr 
3+ 
Be  ,  Ca  ,  '  ' 
Fe  ,  Hg  ,  Mn  ,  NI  ,  Al  ,  Au  ,  ' 
G  3+  3+  4+  4+  4+  +  B.3+  Pb
2 ~ Tl+  6+  5+  M  6+ 
a  '  La  ,  Ir  , Sn  ,  Zr  ,  Ag  ,  I  '  '  u  ,  As  ,  0  ' 
v 5+  Sb5+  4+ 
'  ' 
Se  • 
6. 4. 2  The Biosynthesis of Cd-BP in Short-term Experiments: Normal 
Level of Cd-BP in the Rat 
Th  ·  1  ·  ·  f  109  d  d 
3 5s  ·  ·  Cd  P  e  simu taneous Incorporation o  C  an  -cysteine Into  -B 
and its isolation as described under section 6. 1,  was used to study the bio-
synthesis of Cd-BP in subacute exposures to cadmium.  Some conclusions 
seem valid: 
- the biosynthesis of Cd-BP is controlled by the cadmium concentration 
also in the presence of other heavy metals (section 6. 4. l ); 
- when rats are intoxicated daily with amounts of cadmium of 0. 8  mg/kg 
for 8  days,  the biosynthesis is linear with the cadmium concentration 
(Figure 8); 
- the daily dietary intake for rats is of the order of 5 /g cadmium (confir-
med by neutron activation analysis of the diet).  This quantity should be - 22  -
sufficient to synthesize the amount of Cd-BP corresponding to the 
fraction adsorbed (6o/o  from literature data  (
55
)).  The Cd-BP should 
therefore be normally present in the rat liver.  The hypothesis seems 
confirmed by the experiments described under section 6. 3 and 7  on 
the incorporation of various metals in the Cd-BP.  It was found that 
a  small amount of the different metal ions incorporated in the Cd-BP 
65  64  197  113  110m 
of Cd-treated rats (  Zn,  Cu,  Hg,  Sn and  Ag) is also pre-
sent in normal animals (without Cd-treatment),probably due to minute 
amounts of Cd-BP not detectable by UV -measurement. 
7.  DISTRIBUTION OF HIGH SPECIFIC ACTIVITY RADIOTRACERS IN 
THE SUBCELLULAR FRACTIONS FROM RAT  LIVER: SYSTEMATIC 
STUDY IN THE SOLUBLE FRACTION 
A  systematic study of the distribution in rats of radiotracers,  shows 
that liver and kidney are important deposition organs of many heavy me-
tals(56).  The knowledge of the subcellular distribution of heavy metals, 
which is of great importance to understand the biochemical effects in 
rats intoxicated with pollutant elements,  is far from being investigated. 
We have systematically examined in vivo the distribution of radiotrace rs 
in the soluble fractions of rat liver.  Animals were injected i. p.  with 
radioactive metal ions and sacrificed after 24 hours.  The soluble frac-
tion of liver homogenate,  obtained by centrifugation at 105.000 x  g  for 
90 min,  was chromatographed on Sephadex G-7 5 column (1 00 x  5 em) and 
proteins and radioactivities measured in the collected fractions as des-
c ribed in section 6. l.  The results are illustrated in Figure 9: 
- all radiotrac  e rs were always recovered from the supernatant after Se-
phadex G-7 5 chromatography in association with the fraction of high 
201  51  7  203  65 
molecular weight components,  although  Tl,  C r,  Be,  Pb,  Zn, 
197  113 
Hg,  Sn are also present in the fractions corresponding to low 
molecular weight; 
109  110m 
- Cd and  Ag were present only in the Cd-BP region (MW '=  10. 000); - 2 3  -
-
198 
Au was also associated with a  fraction corresponding to a  molecu-
lar weight of 5. 000  - 6. 000; 
64 
Cu is associated with a  fraction corresponding to Cd-BP and with 
a  more specific protein,  probably cytocuprein(
57
)  of moleculq.r weight 
30.000  - 35.000. 
In conclusion,  it appears that high molecular weight components of 
the soluble fraction of rat liver,  are greatly involved in the metabolism 
of many heavy metals.  The study of the biochemical nature of these com-
ponents will give us informations in view to identify the intracellular me-
tal-binding site(s). 
8.  PRELIMINARY RESULTS ON BIOCHEMICAL EFFECTS OF LEAD 
Di Ferrante and Bordeau  ( SS)  recently reviewed the distribution of 
stable and radioactive lead (
210
Pb) in different organs of man and con-
cluded that data on the distribution of lead in the different compartments 
of the organism are far from being consistent.  In addition,  very few works 




).  The purpose of this 
study was to investigate the distribution of 
203
Pb in organs,  subcellular 
fractions,  components of purified subcellular fractions and molecular 
components of fractioned subcellular fractions.  The study has been car-
ried out by means of 
203
Pb radioisotope which has favourable nuclear 
characteristics for short-term experiments(59).  The use of 
210
Pb in the 
study of lead metabolism is limited by the high toxicity of the daughter 
210 
Po and by the difficulty of measuring accurately the counting rate of 
the emitted 0(-radiation. 
8  1  .  .  f  203Pb  .  Preparation and Counting o  -------------------------------
203 
Fig.  10 shows the excitation function for the production of  Pb by 
203 
proton irradiation of thallium target  •  The purification of  Pb was car-
ried out by double coprecipitation with ferric hydroxide and subsequent 
extraction of iron by propylether.  Further purification from thallium traces - 24  -
was performed by cation exchange resin. 
1  f 
203  b  d"  .  .  d  b  y  A  1 measurements o  P  ra 1oact1v1ty were  one  y  fJ  -ray spectros-
copy with a  Ge(Li) detector at the characteristic line of 279 KeV. 
8  2  .  .  f  2 O  3 Pb .  T.  •  Distr1but1on o  1n Rat  1s sues 
18 fg of stable lead nitrate/rat plus 700 fCi of 
203
Pb carrier-free/ 
rat were injected i. v.  to eight animals.  The rats were sacrificed after 
24 h.  by heart puncture after ether anaesthesia.  Blood was collected and 
the organs removed and homogenized.  Aliquots of homogenates were di-
rectly counted for 
203
Pb radioactivity.  The results are reported in Fig. 11. 
203 
- Subcellular distribution of  Pb in rat liver and kidney: gel chromato-
graphy of soluble fractions from liver,  kidney and spleen 
The homogenates of liver and kidney were fractioned by differential 
.  f  .  Th  2 O  3 Pb  d.  .  .  d  .  1  .  centr1 ugat1on.  e  ra  1oact1v1ty was measure  1n nuc ear,  m1to-
chondrial,  lysosomal,  microsomal and soluble fractions.  Further puri-
fication of nuclei and mitochondria  has been carried out (see procedu-
res in Fig.  1 ).  The results are shown in Fig.  11  and 12.  The soluble 
fractions from kidney,  liver and spleen were chromatographed on Sepha-
dex G-75 column as reported for the isolation of Cd-BP (see section 6. 1). 
203 
The UV adsorbance and  Pb radioactivity profiles from gel ch.romato-
graphy are shown in Fig.  13. 
·  "b  ·  f  203Pb .  h  f  1  .  d  .  h  d  .  - D1str1  ut1on o  1n t  e  components o  nuc e1 an  m1toc  on  r1a 
from· liver and kidney 
Purified liver and kidney nuclei and mitochondria  were respectively 
fractioned in membrane and "bulk chromatine" (:q.uclei) and soluble,  in-
terface,  light and heavy fractions (rnitochondriae) (see procedures in 
Fig.  2).  The 
203
Pb radioactivity was measured in these fractions {Fig. 
11  and 12). - 25  -
- Chromatographic separation of liver and i:idney nuclear chromatine 
and soluble mitochondrial fractions 
The nuclear "bulk chromatine" and the mitochondrial soluble frac-
tion from liver and kidney were chromatographed on Sephadex G-7 5 co-
lumn and the UV absorbance and 
203
Pb radioactivity profiles were mea-
sured.  The results are shown in Fig.  11 and 12. 
The following conclusions can be drawn from the experiments which 
were described above: 
- Rat kidney and liver are the organs in which most of 
203
Pb can be re-
covered after 24 h.  from a  single i. v.  injection. 
- The subcellular distribution of 
203
Pb shows that most of the radiolead 
was contained in the nuclear and soluble fractions of kidney and liver. 
Mitochondria  of kidneys bind much more lead than those of liver. 
- Gel chromatography of soluble fractions from liver,  kidney and spleen 
show that 
203
Pb are associated almost with fractions corresponding to 
high molecular components. 
-About 65-70% of 
203
Pb in nuclei is associated with membrane,  while 
about 30% is present in the chromatine.  In this latter case radiolead 
is present in one protein peak. 
- Different distribution of 
203
Pb in the mitochondria  components of kid-
ney and liver were obtained.  However,  gel chromatography of mitochon-
203 
drial soluble fractions shows association of  Pb radioactivity with 
fractions corresponding to high molecular weights. 
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TABLE  1  FLOW  -SHEET OF SYSTEMATIC STUDY 

























- preparation of tracer 
- valence state tests 
- stability of cone.  and diluted solutions 
Systematic Run 
start,  ten animals are sacrificed at inter-
val of ten days 
obtaining data on cumulation of tracer in 
organs,  cellular fractions,  isolated orga-
nelles and their components.  On cumula-
ted fractions make gel chromatography 
separations 
Final characterization and in vitro studies 
- analytical electrophoresis 
- characterization (elemental composition, 
stoichiometric ratios,  binding sites •.• ) 











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































 tELL  FRACTiONATiON  OF  RAT  L'IVER 
Tissue  homo~et\af:e 
(  o.2s M tuose ,  Tris·HC:I  rH =  72) 
Filtrdtion  by cheese  cloth 
roo  ~  ~  Resiat~~  ..,__ _____  ,.  CTude.  Nu~Lfi 
IO  mirt 
.Su per"ata"t 




~--~o_.ooo_•......__R_rs_id_ut~Crvdt  LYSOSOHES 
1"'"'i" 
s  u re.rnatar\t 
Supnnattnt  ._ ______  _:' So\o~\t c:rroPLIISHAli~ 
fYaction 
PUR.IFiCATiON  OF  RAT  LiVfR  MiTOCHOND~iA 
(G.L.Soltocas~ ,J: "rCell  B.ol. (  13~1). 3Z.415) 
Resuspenq  ··erode  HiTocHoiiDRiA..  •  ... 
0-2.5'1t  suc:rose 
24ooo a'  So~un~t~  .. t 
10 min 
~'Ott •'  Su~errutaMt 
t---------•  1).-s,~rf/. 
2S ""i" 
(s~;  ... ~'"'' rotor) 
Re~ialoe :PuRifiED  HiTocHotiJ>RiA 
fURiFi CATiON  OF  RAT  LiVER  NUCLEi 
( W  \>rfr~nKe, E1.ptl  Cell  Res.  (  1313). 81.365) 
Resvspe"~ ''crodt. llucLEi ..  ia 
o.4s-M  Suero.se. o:Of tt  KCI  ,o.o~ Tr•.s·~CI  pH= 1-.Z 
~  Atit/  7 volu~tte.s  of  ''Je,se  sucrose  so/vt.onu 
(2.011  Sucrose ,o.011f KCI. O.Oi Tris-HCJ  ~H:7-2) 
~  Layer  over  d  lar9e  vo/u.,e  of ''o/eHtt. 
sucro~e-' solut,·on,, 
220()()  ~ ~  Su~erna~.,t  J 
1----------..  ..])i.SCarq,  ro  mi, 
Resusbend  ··"  0.311  Sucrose  0.0111  h'CI  a.o~V'r.'I  f!Ct tJ/!}2 
I~  I  I  I 
Adjust  soc. rose  con c  e" tra t;on  to  /.8M  ,,.&J,  i  •dense  meJ,·c~rn. 
L.ayer  o~er  a~ e'ua/  volutt1f  •f "~ett~e .ro/ufi·an. 
6oooo • o  Superna ta~  1:. 
~--=c.J:.-..,_ ___  ,... IJ  i gc  art:L 
!Jo ntin 
Re.~'due : Pu~i  flED  NuCLEi. 
PVRi FiCATiDN  oF  RA.T  LiVER  MiCROSOHES 
( J: J. M.  Ber~Ton.  'J. or Cell  Bioi.  (l~l3),  5~.  1~) 
Resuspewu!  ''MicRosoMiAL  fractiott,  ,·., 






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































 Cold  YOOIII  radiothemical 
fatdity 
Modular  ca~e 
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Stabularium 
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132 Te 
192lr  197Hg 
2o1rt 
I  I  1 
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elution  volume  (ml) 
Fi~ure 9.  Distribution of rad;oifac~rs in  sohJble  prac.-holll 
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